Hubbry Logo
search button
Sign in
Tiflucarbine
Tiflucarbine
Comunity Hub
arrow-down
History
arrow-down
starMore
arrow-down
bob

Bob

Have a question related to this hub?

bob

Alice

Got something to say related to this hub?
Share it here.

#general is a chat channel to discuss anything related to the hub.
Hubbry Logo
search button
Sign in
Tiflucarbine
Community hub for the Wikipedia article
logoWikipedian hub
Welcome to the community hub built on top of the Tiflucarbine Wikipedia article. Here, you can discuss, collect, and organize anything related to Tiflucarbine. The purpose of the hub is to connect people,...
Add your contribution
Tiflucarbine

Tiflucarbine
Identifiers
  • 9-Ethyl-4-fluoro-1-methyl-7,8,9,10-tetrahydro-6H-pyrido[4,3-b]thieno[3,2-e]indole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H17FN2S
Molar mass288.38 g·mol−1
3D model (JSmol)
  • CCN1CCC2=C(C1)C3=C4C(=CSC4=C(C=C3N2)F)C
  • InChI=1S/C16H17FN2S/c1-3-19-5-4-12-10(7-19)15-13(18-12)6-11(17)16-14(15)9(2)8-20-16/h6,8,18H,3-5,7H2,1-2H3
  • Key:BNKIWXODDDABSJ-UHFFFAOYSA-N

Tiflucarbine (BAY-P 4495) is an experimental drug which acts as an agonist of the 5-HT1 and 5-HT2 serotonin receptor families, and also acts as a calmodulin inhibitor. It has antidepressant effects in animal studies.[1][2][3][4] It is similar in structure to but distinct from β-carbolines.

References

[edit]
  1. ^ Maj J, Rogóz Z, Sowińska H, Zalewski Z (1987). "Some central effects of tiflucarbine, a new potential antidepressant drug". Polish Journal of Pharmacology and Pharmacy. 39 (1): 63–74. PMID 2823240.
  2. ^ Glennon RA, De Vry J, Spencer DG, Glaser T (December 1990). "Stimulus properties of tiflucarbine: a novel antidepressant agent". Pharmacology, Biochemistry, and Behavior. 37 (4): 769–771. doi:10.1016/0091-3057(90)90561-u. PMID 2151199.
  3. ^ Schmidt BH, Glaser T, Seidel PR, Traber J (December 1990). "Evidence for a specific recognition site for tiflucarbine on calmodulin". European Journal of Pharmacology. 189 (6): 411–418. doi:10.1016/0922-4106(90)90039-z. PMID 1963605.
  4. ^ Hegemann L, Fruchtmann R, Bonnekoh B, Schmidt BH, Traber J, Mahrle G, et al. (1991). "Effects of tiflucarbine as a dual protein kinase C/calmodulin antagonist on proliferation of human keratinocytes and release of reactive oxygen species from human leukocytes". Archives of Dermatological Research. 283 (7): 456–460. doi:10.1007/BF00371782. PMID 1801655.